Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

119.92
Delayed Data
As of May 26
 +1.32 / +1.11%
Today’s Change
71.46
Today|||52-Week Range
121.96
+62.78%
Year-to-Date

Today’s Trading

Previous close118.60
Today’s open118.10
Day’s range118.05 - 120.82
Volume1,477,802
Average volume (3 months)1,809,048
Market cap$29.9B
Dividend yield--
Data as of 4:14pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+92.71%
Earnings growth (next 5 years)+68.90%
Revenue growth (last year)+64.89%
P/E ratio171.3
Price/Sales10.59
Price/Book25.75

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.03+0.05%
BAXBaxter International...-0.50-0.85%
INCYIncyte Corp-4.03-2.91%
ALXNAlexion Pharmaceutic...-0.80-0.81%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.37
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts